| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.6M | +14.2% | +19.9% |
| Cost of Revenue | $1.6M | +41.4% | +69.9% |
| Gross Profit | $28.9M | +12.9% | +18.0% |
| R&D Expense | $2.4M | -31.0% | -14.8% |
| SG&A Expense | $4.3M | -40.6% | +13.0% |
| Operating Income | $6.9M | +219.0% | +63.6% |
| Pre-tax Income | $7.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.4M | +10.7% | +154.6% |
| Short-term Investments | $19.6M | +9.9% | +113.0% |
| Accounts Receivable | $25.9M | +5.1% | — |
| Inventory | $8.9M | -0.1% | +38.8% |
| Current Assets | $98.6M | +8.0% | +79.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.6M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | -$2.3M | — | — |
| Financing Cash Flow | $24.1M | — | — |
| Free Cash Flow | $5.6M | — | — |
| +240.9% |
| +94.1% |
| Income Tax | $1.7M | +155.7% | +57.6% |
| Net Income | $5.9M | +276.6% | +107.8% |
| EPS (Basic) | $0.04 | — | +300.0% |
| EPS (Diluted) | $0.03 | — | +200.0% |
| $159.4M |
| +4.4% |
| +27.3% |
| Current Liabilities | $15.9M | -6.0% | +8.1% |
| Total Liabilities | $22.0M | -5.3% | -17.9% |
| Stockholders' Equity | $101.9M | +10.8% | +61.3% |